ES2111059T3 - Derivados de hidroxilamina substituidos con heteroarilo como inhibidores de lipoxigenasa. - Google Patents

Derivados de hidroxilamina substituidos con heteroarilo como inhibidores de lipoxigenasa.

Info

Publication number
ES2111059T3
ES2111059T3 ES92810559T ES92810559T ES2111059T3 ES 2111059 T3 ES2111059 T3 ES 2111059T3 ES 92810559 T ES92810559 T ES 92810559T ES 92810559 T ES92810559 T ES 92810559T ES 2111059 T3 ES2111059 T3 ES 2111059T3
Authority
ES
Spain
Prior art keywords
aril
alkyl
inferior
carbociclico
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92810559T
Other languages
English (en)
Inventor
Duzer John H Van
Dennis M Roland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Novartis AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2111059T3 publication Critical patent/ES2111059T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

SE DESCRIBE EL COMPUESTO DE FORMULA DONDE R REPRESENTA HIDROGENO, ALQUIL INFERIOR, ARIL, BIARIL, C3-C7CICLOALQUIL, ARIL-ALQUENIL INFERIOR, ARIL-ALQUINIL INFERIOR, ARILTIO-ALQUIL INFERIOR, C3-C7-CICLOALQUIL-ALQUIL INFERIOR, BIARIL-ALQUIL INFERIOR, ARIL-C3-C7-CICLOALQUIL, ARIL-C3-C7CICLOALQUIL-ALQUIL INFERIOR O ARILOXI-ARIL-ALQUIL INFERIOR, Y ARIL REPRESENTA ARIL CARBOCLICICO O HETEROCICLICO, Z REPRESENTA C1-C3-ALQUILENO O VINILENO, CADA UNO SUBSTITUIDO O NO POR ALQUIL INFERIOR; Y REPRESENTA SO2 (SULFONIL) O CO (CARBONIL); A REPRESENTA O (OXIGENO), S (AZUFRE) O UN ENLACE DIRECTO; B REPRESENTA ALQUILENO INFERIOR; O B REPRESENTA ALQUILENO INFERIOR SUPUESTO QUE A REPRESENTA UN ENLACE DIRECTO; X REPRESENTA OXIGENO O AZUFRE; R1 REPRESENTA HIDROGENO, ACIL, ALCOXICARBONIL INFERIOR, AMINOCARBONIL, ALQUILAMINOCARBONIL MONO ERIOR, ALQUINILAMINOCARBONIL INFERIOR, ARIL CARBOCICLICO O HETEROCICLICO-ALQUILAMINOCARBONIL INFERIOR, ARILAMINOCARBONIL CARBOCICLICO O HETEROCICLICO, C3-C7CICLOALQUILAMINOCARBONILO C3-C7-CICLOALQUIL QUI INFERIOR, ALCOXICARBONIL INFERIOR-ALQUIL INFERIOR, C3-C7-CICLOALQUIL, ARIL CARBOCICLICO O HETEROCICLICO, AMINO, ALQUILAMINO MONO INFERIOR, ARIL CARBOCICLICO O HETEROCICLICOALQUILAMINO INFERIOR, ARILAMINO CARBOCICLICO O HETEROCICLICO, C3C7-CICLOALQUILAMINO, C3-C7-CICLOALQUIL-ALQUILAMINO INFERIOR O ALCOXICARBONIL INFERIOR-ALQUILAMINO INFERIOR; R3 Y R4 INDEPENDIENTEMENTE REPRESENTAN HIDROGENO O ALQUIL INFERIOR; RA REPRESENTA HIDROGENO, ALQUIL INFERIOR, HALO, TRIFLUOROMETIL O ALCOXI INFERIOR; Y SUS SALES FARMACEUTICAMENTE ACEPTABLES; QUE SON UTILIES COMO INHIBIDORES DE LIPOXIGENASA.
ES92810559T 1991-07-30 1992-07-21 Derivados de hidroxilamina substituidos con heteroarilo como inhibidores de lipoxigenasa. Expired - Lifetime ES2111059T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73807591A 1991-07-30 1991-07-30

Publications (1)

Publication Number Publication Date
ES2111059T3 true ES2111059T3 (es) 1998-03-01

Family

ID=24966464

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92810559T Expired - Lifetime ES2111059T3 (es) 1991-07-30 1992-07-21 Derivados de hidroxilamina substituidos con heteroarilo como inhibidores de lipoxigenasa.

Country Status (21)

Country Link
EP (1) EP0526402B1 (es)
JP (1) JPH0641104A (es)
KR (1) KR930002329A (es)
AT (1) ATE162525T1 (es)
AU (1) AU662339B2 (es)
CA (1) CA2074797A1 (es)
CZ (1) CZ235192A3 (es)
DE (1) DE69224115T2 (es)
DK (1) DK0526402T3 (es)
ES (1) ES2111059T3 (es)
FI (1) FI923393A7 (es)
GR (1) GR3026254T3 (es)
HU (1) HUT66626A (es)
IE (1) IE922471A1 (es)
IL (1) IL102612A (es)
MX (1) MX9204418A (es)
NO (1) NO178925C (es)
NZ (1) NZ243752A (es)
PH (1) PH30092A (es)
TW (1) TW281672B (es)
ZA (1) ZA925688B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6268392B1 (en) 1994-09-13 2001-07-31 G. D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US6262277B1 (en) 1994-09-13 2001-07-17 G.D. Searle And Company Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US5516789A (en) * 1995-04-12 1996-05-14 Abbott Laboratories Lipoxygenase and cyclooxygenase inhibiting compounds
BE1010487A6 (nl) 1996-06-11 1998-10-06 Unilin Beheer Bv Vloerbekleding bestaande uit harde vloerpanelen en werkwijze voor het vervaardigen van dergelijke vloerpanelen.
AU2157400A (en) 1998-12-23 2000-07-31 G.D. Searle & Co. Combinations of cholesteryl ester transfer protein inhibitors and hmg coa reductase inhibitors for cardiovascular indications
PT1140190E (pt) 1998-12-23 2003-02-28 Searle Llc Combinacoes de inibidores do transporte ileal dos acidos biliares e agentes sequestrantes dos acidos biliares usadas para problemas cardiovasculares
EP1342475A1 (en) 1998-12-23 2003-09-10 G.D. Searle LLC. Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
DK1140185T3 (da) 1998-12-23 2003-09-29 Searle Llc Kombinationer af cholesterylestertransferhæmmere og galdesyre kompleksdannende forbindelser til hjertekar indikationer
MXPA01006472A (es) 1998-12-23 2004-03-10 Searle Llc Combinaciones de inhibidores de transporte de acido biliar ileal y derivados de acido fibrico para indicaciones cardiovasculares.
EP1140186B1 (en) 1998-12-23 2003-06-04 G.D. Searle LLC. Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
DK1140184T3 (da) 1998-12-23 2003-09-29 Searle Llc Kombinationer af cholesterylestertransferproteinhæmmere og nikotinsyrederivater til hjertekar indikationer
EP1286984A2 (en) 2000-03-10 2003-03-05 Pharmacia Corporation Method for the preparation of tetrahydrobenzothiepines
DE10103506A1 (de) * 2001-01-26 2002-08-14 Ingo S Neu Pharmazeutische Zusammensetzung zur Behandlung von Multiple Sklerose
US6740663B2 (en) 2001-11-02 2004-05-25 G.D. Searle, Llc Mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake
AU2003207431A1 (en) 2002-01-17 2003-09-02 Pharmacia Corporation Novel alkyl/aryl hydroxy or keto thiepines.
DE10229762A1 (de) * 2002-07-03 2004-01-22 Aventis Pharma Deutschland Gmbh Pyrazoloisoquinolinenderivaten zur Inhibierung von NFkappaB-induzierende Kinase
EP1572660B1 (en) 2002-12-20 2011-01-26 X-Ceptor Therapeutics, Inc. Isoquinolinone derivatives and their use as therapeutic agents
EP3509588B1 (en) 2016-09-12 2023-06-07 Integral Health,Inc. Bicyclic compounds useful as gpr120 modulators
KR102537985B1 (ko) 2016-09-12 2023-05-30 인테그랄 헬스 인코퍼레이티드 Gpr120 조정제로서 유용한 단환형 화합물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ215487A (en) * 1985-03-16 1990-01-29 Wellcome Found Aryl derivatives, pharmaceutical compositions thereof and preservation of cut flowers
US4761403A (en) * 1986-04-09 1988-08-02 Abbott Laboratories Lipoxygenase inhibiting compounds
EP0279263B1 (en) * 1987-02-10 1993-08-04 Abbott Laboratories Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds
US4981865A (en) * 1989-05-26 1991-01-01 Warner-Lambert Co. N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents

Also Published As

Publication number Publication date
HUT66626A (en) 1994-12-28
EP0526402B1 (en) 1998-01-21
FI923393A7 (fi) 1993-01-31
MX9204418A (es) 1993-02-01
ZA925688B (en) 1993-03-31
IL102612A (en) 1996-11-14
AU662339B2 (en) 1995-08-31
HU9202479D0 (en) 1992-10-28
ATE162525T1 (de) 1998-02-15
GR3026254T3 (en) 1998-05-29
IL102612A0 (en) 1993-01-14
JPH0641104A (ja) 1994-02-15
CA2074797A1 (en) 1993-01-31
DE69224115T2 (de) 1998-08-20
NO922987L (no) 1993-02-01
NO178925C (no) 1996-07-03
FI923393A0 (fi) 1992-07-27
DK0526402T3 (da) 1998-09-14
EP0526402A1 (en) 1993-02-03
NO178925B (no) 1996-03-25
KR930002329A (ko) 1993-02-23
IE922471A1 (en) 1993-02-10
AU2048292A (en) 1993-02-04
NO922987D0 (no) 1992-07-29
NZ243752A (en) 1994-09-27
TW281672B (es) 1996-07-21
CZ235192A3 (en) 1993-10-13
DE69224115D1 (de) 1998-02-26
PH30092A (en) 1996-12-27

Similar Documents

Publication Publication Date Title
ES2065133T3 (es) Derivados de piperazina.
ATE188964T1 (de) Pyrimidinderivate und verfahren zu ihrer herstellung
CO5050295A1 (es) Activadores trans olefinicos de la glucokinasa
DE69902634D1 (de) Substituierte aminophenylisoxazolinderivate verwendbar als antimikrobielle agenzien
ATE47845T1 (de) Guanidin-derivate.
ES8703142A1 (es) Proceso para preparar un derivado del bencimidazol.
DE69717970D1 (de) Chinolin carbonsaure-derivate und ihre salze
MY101176A (en) Heterocyclic compounds as fungicides
DK306586D0 (da) Pyridoncarboxylsyre-derivater og fremgangsmaade til fremstilling deraf
ATE155465T1 (de) Phenoxy- oder phenoxyalkyl-piperidine als antivirale mittel
ES2149951T3 (es) Producto pseudodipeptido que posee un grupo imidazol y aplicaciones del mismo.
UY24010A1 (es) Nuevos pirrolocarbazoles
NO934628L (no) Retrovirus-protease-inhibitorer
DE69224115D1 (de) Heteroaryl substituierte Hydroxylaminderivate als Lipoxygenase-Inhibitoren
ES8506638A1 (es) Procedimiento para la obtencion de 5-acilamino-1-fenilpirazoles sustituidos
PH19685A (en) Pharmaceutically active pyridine carboxylic acid
DK0641567T3 (da) Stabile farmaceutiske præparater indeholdende hybrid alfa-interferon
DK0736009T3 (da) N-oxider af 4-arylpiperaziner og 4-arylpiperidiner som antipsykotiske medikamenter
HUT38504A (en) Herbicides containing as reagent derivatives of substituated 5-/acil-amin/-1-phenil-piradosole and process for production of the compound
MX9704435A (es) Compuestos de tiazolidinona y agente terapeutico o agente de prevencion para angina de pecho, que comprende los compuestos como un ingrediente activo.
CO4761036A1 (es) Mezclas fungicidas
DK1224166T3 (da) Fremgangsmåde til fremstilling af N-(4,5-bis-methansulfonyl-2-methyl-benzoyl)-guanidin-hydrochlorid
AR248276A1 (es) Derivados de imidazolidina, procedimiento para producirlos y pesticidas que los contienen
DE69319900D1 (de) N,n'-disubstituierte amidderivate
NO972905L (no) Tienoksasinon-derivater anvendelige som antivirusmidler

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 526402

Country of ref document: ES